Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mounjaro
Biotech
The most valuable R&D projects? You guessed it: obesity
The obesity game is in its early innings, and the future will be defined by who can ease administration, according to a new report from Evaluate.
Annalee Armstrong
Jul 11, 2024 5:00am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
Lilly uses Mounjaro millions to hunt for biotech partners
May 1, 2024 9:26am
Lilly's obesity portfolio in 'all-of-the-above mode'
Nov 2, 2023 11:15am
Lilly, BioAge to test muscle regeneration drug with tirzepatide
Oct 26, 2023 11:39am
Lilly's next obesity drug just cut an average of 58 pounds
Jun 26, 2023 8:45pm
